rewirebio.iobenchmarks
Dataset

SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions

SEQC2 HCC1395 tumour WGS used tumour-only; truth is the SEQC2 high-confidence call set (about 39,000 SNVs).

Evaluation results

18 evaluations · 18 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: ClairS-TO v0.4.0, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.2 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

ClairS-TO on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'ClairS-TO', column 'SEQC2 INDEL'
Configuration: ClairS-TO v0.4.0, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.543 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

ClairS-TO on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'ClairS-TO', column 'SEQC2 SNV'
Configuration: DeepSom-BLCA, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.469 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-BLCA on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-BLCA', column 'SEQC2 INDEL'
Configuration: DeepSom-BLCA, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.54 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-BLCA on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-BLCA', column 'SEQC2 SNV'
Configuration: DeepSom-ESAD, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.363 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-ESAD on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-ESAD', column 'SEQC2 INDEL'
Configuration: DeepSom-ESAD, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.577 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-ESAD on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-ESAD', column 'SEQC2 SNV'
Configuration: DeepSom-GACA, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.257 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-GACA on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-GACA', column 'SEQC2 INDEL'
Configuration: DeepSom-GACA, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.246 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-GACA on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-GACA', column 'SEQC2 SNV'
Configuration: DeepSom-LAML, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.097 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-LAML on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-LAML', column 'SEQC2 INDEL'
Configuration: DeepSom-LAML, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.464 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-LAML on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-LAML', column 'SEQC2 SNV'
Configuration: DeepSom-LINC, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.462 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-LINC on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-LINC', column 'SEQC2 INDEL'
Configuration: DeepSom-LINC, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.575 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepSom-LINC on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'DeepSom-LINC', column 'SEQC2 SNV'
Configuration: Deepsomatic (tumor-only) v1.7.0, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.45 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Deepsomatic (tumor-only) on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'Deepsomatic (tumor-only)', column 'SEQC2 INDEL'
Configuration: Deepsomatic (tumor-only) v1.7.0, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.351 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Deepsomatic (tumor-only) on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'Deepsomatic (tumor-only)', column 'SEQC2 SNV'
Configuration: Mutect2 (tumor-only), tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.003 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Mutect2 (tumor-only) on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'Mutect2 (tumor-only)', column 'SEQC2 INDEL'
Configuration: Mutect2 (tumor-only), tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.078 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Mutect2 (tumor-only) on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'Mutect2 (tumor-only)', column 'SEQC2 SNV'
Configuration: VarNet-T, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, indels, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.527 AUPRC (indel only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

VarNet-T on seqc2-indel tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-indel

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'VarNet-T', column 'SEQC2 INDEL'
Configuration: VarNet-T, tumour-only Illumina WGS (Krishnamachari et al. 2026)Protocol: SEQC2 HCC1395 tumour-only, SNVs, AUPRC (Krishnamachari et al. 2026 Supplementary Table 1)
Dataset: SEQC2 HCC1395 tumour Illumina HiSeq WGS (WGS_IL_T_1), high-confidence regions
0.773 AUPRC (SNV only, tumour-only)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

VarNet-T on seqc2-snv tumour-only (Krishnamachari et al. 2026)

somatic-varnet-t-20261011-protocol-seqc2-snv

Aggregation: Not reported

Improved tumor-only variant calling and mutation burden estimation with VarNet-T; VarNet-T Supplementary Information; VarNet-T Source Data workbook · Supplementary Table 1, row 'VarNet-T', column 'SEQC2 SNV'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

24 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Accession
SRA SRX4728512 and related (Data availability)
Context-only references
Improved tumor-only variant calling and mutation burden estimation with VarNet-T

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2026-04-09; PMC13243554 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.accession

Source artifact SHA-256: b42db521781cd548b5ce0cf99233f8e790781fb5e8953fe733202009dd8367bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Accession
SRA SRX4728512 and related (Data availability)
Context-only references
VarNet-T Source Data workbook

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Source Data file (41467_2026_71705_MOESM6_ESM.xlsx)
Retrieved: 2026-10-11T21:51:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.accession

Source artifact SHA-256: 4a2deae733ff93a9ae0001053816d82fb60787b01646183c8d37fbc5a764cd17

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Accession
SRA SRX4728512 and related (Data availability)
Context-only references
VarNet-T Supplementary Information

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information PDF (41467_2026_71705_MOESM1_ESM.pdf), 28 pages
Retrieved: 2026-10-11T21:51:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.accession

Source artifact SHA-256: c808b4361e17a64911a59ded81d9db04c7a3dd5ba95fb3e1e060a293182f2842

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
Illumina WGS aligned with BWA-MEM (bcbio-nextgen) to GRCh38
Context-only references
Improved tumor-only variant calling and mutation burden estimation with VarNet-T

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2026-04-09; PMC13243554 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: b42db521781cd548b5ce0cf99233f8e790781fb5e8953fe733202009dd8367bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
Illumina WGS aligned with BWA-MEM (bcbio-nextgen) to GRCh38
Context-only references
VarNet-T Source Data workbook

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Source Data file (41467_2026_71705_MOESM6_ESM.xlsx)
Retrieved: 2026-10-11T21:51:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 4a2deae733ff93a9ae0001053816d82fb60787b01646183c8d37fbc5a764cd17

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
Illumina WGS aligned with BWA-MEM (bcbio-nextgen) to GRCh38
Context-only references
VarNet-T Supplementary Information

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information PDF (41467_2026_71705_MOESM1_ESM.pdf), 28 pages
Retrieved: 2026-10-11T21:51:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: c808b4361e17a64911a59ded81d9db04c7a3dd5ba95fb3e1e060a293182f2842

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
SEQC2 HCC1395 tumour WGS
Context-only references
Improved tumor-only variant calling and mutation burden estimation with VarNet-T

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2026-04-09; PMC13243554 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: b42db521781cd548b5ce0cf99233f8e790781fb5e8953fe733202009dd8367bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
SEQC2 HCC1395 tumour WGS
Context-only references
VarNet-T Source Data workbook

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Source Data file (41467_2026_71705_MOESM6_ESM.xlsx)
Retrieved: 2026-10-11T21:51:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 4a2deae733ff93a9ae0001053816d82fb60787b01646183c8d37fbc5a764cd17

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
SEQC2 HCC1395 tumour WGS
Context-only references
VarNet-T Supplementary Information

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information PDF (41467_2026_71705_MOESM1_ESM.pdf), 28 pages
Retrieved: 2026-10-11T21:51:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: c808b4361e17a64911a59ded81d9db04c7a3dd5ba95fb3e1e060a293182f2842

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Truth: SEQC2 consortium reference call set in its high-confidence regions, about 39,000 SNVs.
Context-only references
Improved tumor-only variant calling and mutation burden estimation with VarNet-T

Original source ↗

Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2026-04-09; PMC13243554 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: b42db521781cd548b5ce0cf99233f8e790781fb5e8953fe733202009dd8367bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-varnet-t-20261011-data-seqc2

areas
dna-genomes
contexts
clinical_research
population
SEQC2 HCC1395 tumour WGS
assay
Illumina WGS aligned with BWA-MEM (bcbio-nextgen) to GRCh38
accession
SRA SRX4728512 and related (Data availability)
split
Not used in VarNet-T training
scope note
Truth: SEQC2 consortium reference call set in its high-confidence regions, about 39,000 SNVs.
source locator
Results 'Benchmarking on somatic reference datasets', 'Benchmarking using whole cancer genomes from PCAWG', 'Challenges in tumor samples with low somatic mutation burden'; Methods 'Sample processing and in silico dilutions', 'PCAWG benchmark samples'; Data availability
missing metadata
version: reason: unreported
Related records

Suggest a correction